医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

AHF: It’s China’s Turn to Declassify COVID data

2023年03月22日 AM02:50
このエントリーをはてなブックマークに追加


 

LOS ANGELES

President Biden signed into law yesterday a bill requiring the declassification of as much information as possible related to the origins of COVID-19. AIDS Healthcare Foundation (AHF) applauds the legislation and its bipartisan support and encourages China to follow suit in being transparent about all the data it has on how the outbreak began.

“We’re more than three years removed from the start of the COVID-19 pandemic, so declassifying data to help discern the virus’s origin is definitely a step in the right direction,” said Terri Ford, Chief of Global Advocacy and Policy at AHF. “That said, without China’s cooperation and transparency in revealing everything it knows about what happened in Wuhan in 2019, the world will remain more vulnerable to deadly infectious disease outbreaks. We call on China to release all its data immediately – the world and the nearly seven million people who have died because of SARS-CoV-2 deserve to know the truth.”

About AIDS Healthcare Foundation (AHF)

AIDS Healthcare Foundation (AHF) is a global non-profit organization providing cutting-edge medicine and advocacy to over 1.7 million people in 45 countries worldwide in the US, Africa, Latin America/Caribbean, the Asia/Pacific Region, and Europe. We are currently the largest non-profit provider of HIV/AIDS medical care in the world. To learn more about AHF, please visit our website: www.aidshealth.org, find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230321005892/en/

CONTACT

US MEDIA CONTACT:

Ged Kenslea, Senior Director, Communications, AHF

+1 323 308 1833 work

+1.323.791.5526 mobile

gedk@aidshealth.org

Denys Nazarov, Director of Global Policy & Communications, AHF

+1 323.308.1829

denys.nazarov@aidshealth.org

TimeLine:

同じカテゴリーの記事 

  • Delta-Fly Pharma Inc.: Phase I/II Combo-study of DFP-10917 with Venetoclax in Patients with AML Initiates Enrollment of Patients
  • ZTI Biosciences Engages EF Hutton as Strategic and Financial Advisor
  • Osivax and KM Biologics Enter Exclusive License Option Agreement for Broad-Spectrum “Universal” Influenza Vaccine in Japan
  • フランスのサン=ドニ総合病院が早産児の早期退院を促進するためにMasimo SafetyNet®の遠隔モニタリングを導入
  • 法国Saint-Denis Hospital Center实施Masimo SafetyNet®远程监测以方便早产儿尽早出院